Literature DB >> 19691933

The inflammatory milieu in idiopathic inflammatory myositis.

Ann M Reed1, Floranne Ernste.   

Abstract

The idiopathic inflammatory myopathies (IIM) are systemic autoimmune diseases that have predominant mononuclear inflammatory cell infiltrates in the skeletal muscle. The cells that are typically involved in the pathogenesis of disease are B-lymphocytes, T-lymphocytes, macrophages, dendritic cells, and natural killer cells. However, in addition to these immune cells, cells of nonimmunologic origin, such as myocytes, may be directly involved in the immune response. The local milieu also consists of distinct cytokine and chemokine profiles considered related to type 1 interferon stimulation. Tumor necrosis factor and interleukin 1 are also prominent, proinflammatory cytokines involved in the evolution of IIM. Although the pathologic processes involved in IIM have yet to be fully elucidated, we understand the inflammatory milieu is a model of dynamic flux made of diverse cytokine and chemokine expressions leading to alterations in muscle fiber structure and function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691933     DOI: 10.1007/s11926-009-0041-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  65 in total

1.  Myeloid dendritic cells in inclusion-body myositis and polymyositis.

Authors:  Steven A Greenberg; Geraldine S Pinkus; Anthony A Amato; Jack L Pinkus
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

Review 2.  Gene expression profiling in human autoimmunity.

Authors:  Emily C Baechler; Franak M Batliwalla; Ann M Reed; Erik J Peterson; Patrick M Gaffney; Kathy L Moser; Peter K Gregersen; Timothy W Behrens
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

3.  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy.

Authors:  J N Whitaker; W K Engel
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

4.  Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells.

Authors:  L Behrens; A Bender; M A Johnson; R Hohlfeld
Journal:  Brain       Date:  1997-06       Impact factor: 13.501

5.  Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis.

Authors:  G Chevrel; G Page; C Granet; N Streichenberger; A Varennes; P Miossec
Journal:  J Neuroimmunol       Date:  2003-04       Impact factor: 3.478

6.  Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis.

Authors:  M R O'Gorman; L Bianchi; D Zaas; V Corrochano; L M Pachman
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

7.  Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.

Authors:  Raghavan Raju; Marinos C Dalakas
Journal:  Brain       Date:  2005-04-27       Impact factor: 13.501

8.  Expression of tumor necrosis factor-alpha in muscles of polymyositis.

Authors:  M Tateyama; I Nagano; M Yoshioka; K Chida; S Nakamura; Y Itoyama
Journal:  J Neurol Sci       Date:  1997-02-27       Impact factor: 3.181

Review 9.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

10.  MHC Class I overexpression on muscles in early juvenile dermatomyositis.

Authors:  Charles K C Li; Hemlata Varsani; Janice L Holton; Bin Gao; Patricia Woo; Lucy R Wedderburn
Journal:  J Rheumatol       Date:  2004-03       Impact factor: 4.666

View more
  10 in total

1.  Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.

Authors:  Sheela Shrestha; Barry Wershil; John F Sarwark; Timothy B Niewold; Teresa Philipp; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2010-09

2.  Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?

Authors:  Lisa G Rider; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2010-09

Review 3.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 4.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

5.  Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis.

Authors:  Dong Xue Wang; Xin Lu; Ning Zu; Bing Lin; Li Ying Wang; Xiao Ming Shu; Li Ma; Guo Chun Wang
Journal:  Clin Rheumatol       Date:  2012-08-30       Impact factor: 2.980

6.  Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis.

Authors:  Li Zhang; Xiao-Hong Fu; Yong Yu; Ruo-Hong Shui; Chun Li; Hai-Ying Zeng; Yu-Lei Qiao; Li-Yan Ni; Qiang Wang
Journal:  Lab Invest       Date:  2014-11-10       Impact factor: 5.662

Review 7.  Pathogenesis, classification and treatment of inflammatory myopathies.

Authors:  Mei Zong; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2011-04-05       Impact factor: 20.543

Review 8.  Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.

Authors:  Li Zhang; Guoqin Wu; Di Gao; Guijian Liu; Lin Pan; Liyan Ni; Zheng Li; Qiang Wang
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

9.  Identification of hub biomarkers and immune cell infiltration characteristics of polymyositis by bioinformatics analysis.

Authors:  Qi Jia; Rui-Jin-Lin Hao; Xiao-Jian Lu; Shu-Qing Sun; Jun-Jie Shao; Xing Su; Qing-Feng Huang
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

10.  Activated dendritic cells modulate proliferation and differentiation of human myoblasts.

Authors:  Leandro Ladislau; Débora M Portilho; Tristan Courau; Alhondra Solares-Pérez; Elisa Negroni; Jeanne Lainé; David Klatzmann; Adriana Bonomo; Yves Allenbach; Olivier Benveniste; Ingo Riederer; Wilson Savino; Vincent Mouly; Gillian Butler-Browne; Claudia F Benjamim
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 9.685

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.